Company Overview

Who We Are

MaxNova builds innovative medical technology solutions to improve human health globally. By adopting the open innovation approach, we accelerate the processes of new product development, commercialization and Go-To-Market, and create value for our partners and customers.

Problems and Needs

China is now the second largest healthcare market in the world. As an emerging market, it still needs accesses to the innovative medical technologies created from other parts of the world.

Solution

Our Three-Step Solution is designed to solve the market problem and meet its needs. It consists of three steps: Partnerships, China-based Localization and Commercialization, and Go-To-Market. Through the Open Innovation Approach, MaxNova Medical partners with med-tech innovators from all over the world, makes full use of industry resources to localize the products into China, and then brings them to the market.

Value Proposition

It is important because through the Three-Step Solution, MaxNova aims to remove the key entry barriers existing between the advanced technologies and the market needs, and thus create value for both the innovators and patients.

Company Background

MaxNova Medical was founded by a group of medical industry experts. Headquartered in Hong Kong, MaxNova has its operational center in Shenzhen, China, where the core parts of the Three-Step Solution are implemented.

Our Mission

Innovation for Better Life

To make medical technology innovations benefit human health through the open innovation approach that speeds up the processes of product development and commercialization and creates value for our partners and customers.

Why MaxNova Medical

MaxNova Knowledge Book
Knowledge, Experience and Efficiency

MaxNova Medical has a team proven to be knowledgeable and experienced in medical technology industry. In addition, as a world-level business hub, Hong Kong is expected to provide us with a highly efficient platform for both the business operations and intellectual property management.

China Based Location
Removal of Entry Barriers

Our China-based localization and commercialization processes are aimed at essentially removing the entry barriers to China market, and contributing to our innovation partners, hospitals, and patients.

Capital Funding
Markets and Revenues

After the commercialization process of the products, our established marketing and sales team then bring the products to China and other emerging markets, offering the patients with more innovative and cost-effective solutions, and in the meantime, generating real revenues.

Emerging Medical Technologies
Benefits from China Capital Market

To ensure the success of our plans, we take on the responsibility of fund-raising for each of our projects in China and have our mission powered by the Chinese capital market.

Leadership

Our core management consists of a group of industry veterans with profound knowledge in MedTech. We established a global team to implement our Three-Step Solution that serves our mission of contributing to a better life for global patients.

Executive Management

Louis Wang
Chief Executive Officer
A visionary entrepreneur with over 20 years of experience in medical device market. Louis and his teams successfully helped Teledynamics grow to an established brand in China market nationwide, where they extensively worked as a local partner with prestigious medical manufacturers such as Drager, Siemens, Maquet, Carestream, Pentax and so on over the past two decades. With in-depth industry knowledge, Louis and his teams are now helping the global startup partners localize, commercialize, and market their innovative medical devices in China and other emerging markets. Louis has an MBA from the University of Chicago Booth School of Business.
Olga Yanovskaya
President, Global
A global channel management expert in developed and emerging medical device markets. Work, Life and Language experience with leading medical device companies in EMEA, Latin America and APAC. Olga has master’s degree of Healthcare Economics from Universitat Pompeu Fabra and MBA from IE Business School.
Hua Gu
President, USA
A global product strategy and planning manager, with a Ph.D in Materials Engineering. She has a proven track record in complex product development and launches, strategy formulation and implementation. Hua has an MBA from the University of Chicago Booth School of Business.
Kitty Li
Chief Operational Officer
Senior Global Human Resources executive with over 25 years of management experience in Consumer Products, Retail and Manufacturing industries across four continents (Asia, US, Europe, Latin America). Kitty has a proven track record of building successful business startup or turnaround teams via strategic talent management, organization design and culture transformation. Kitty has an MBA from University of Chicago Booth School of Business.
Daniel Zhou
Technology Commercialization
With 10 years of experience in China medical technology industry, Daniel helps overseas MedTech/Biotech start-ups enter the Asian market and raise funds from Chinese investors. He is the business advisor of Office of Technology Commercialization, University of Minnesota. Daniel has an MBA from Bar-Ilan University, Israel.
Li Ye
Business Development, China
Senior marketing and business operations executive. With over 20 years of experience in China healthcare market, Li Ye has a proven track record in marketing and sales with Drager and Maquet. Li is a candidate MBA from the University of Washington.
Young Zhang
GM, Marketing & Sales, China
Highly experienced in Marketing and Sales in healthcare, Young Zhang has successfully helped Televia get a firm foothold across the China’s market. Young has over 10 years of experience in China medical device market, successfully working with the prestigious names such as Siemens, Carestream, Teledynamics, and Medistim. He specialises in carrying out marketing plans and achieving sales goals with his team.
Jack Han
GM, Volume-Based Purchases, China
With solid sales management experience, Jack Han has successfully helped Televia become an established brand in China market. With over 10 years of experience in healthcare, he specialises in helping his team make sales breakthroughs. Jack built up his proven records by developing ice-breaking markets for Carestream and Teledynamics, and he has obvious advantage in winning opportunities of big projects and large purchasing plans from competitive bidding events.
Justin Shen
Chief Financial Officer
Master of Economics, China CPA (non-practising), senior accountant, engaged in corporate financial management for more than 25 years, successively served as financial manager of HK.01893, investment director of AXENT International Group, etc.
Phoenix Zhou
Medical Expert
MD, the University of Hong Kong. Specializing in Cardiovascular Imaging, Phoenix is now working for Sir Run Run Shaw hospital, Zhejiang Chinese University of Medicine. Phoenix is an Oxford PhD Candidate.
Alina Zhang
Strategic Investment, Asia
Alina Zhang is actively involved in the growth investment opportunities, merger and acquisitions of the Company in the sector of healthcare. Ms. Zhang has been investing in the China and other Asian markets for 18 years, with extensive experience across a wide range of industries, including healthcare, consumer, retail, technology, media and telecom as well as has many years of experience of strategic investment planning, financial planning and venture capital fund / private equity fund operations. Ms. Zhang received the degree of Master of Science in Finance from Cass Business School, City University of London and bachelor’s degree in Economics from Zhongnan University of Economics and Law.
Michael Tung
Strategy, Global
Mr. Michael Tung is a veteran private equity professional specializing in growth capital, buyout, mergers, restructuring and other types of alternative investment transactions with a wealth of investment experience in the Greater China and global media and retail sectors. Mr. Tung graduated from Syracuse University majoring in Finance.

Board of Directors

Louis Wang
Chairman
A visionary entrepreneur with over 20 years of experience in medical device market. Louis and his teams successfully helped Teledynamics grow to an established brand in China market nationwide, where they extensively worked as a local partner with prestigious medical manufacturers such as Drager, Siemens, Maquet, Carestream, Pentax and so on over the past two decades. With in-depth industry knowledge, Louis and his teams are now helping the global startup partners localize, commercialize, and market their innovative medical devices in China and other emerging markets. Louis has an MBA from the University of Chicago Booth School of Business.
Olga Yanovskaya
Director
A global channel management expert in developed and emerging medical device markets. Work, Life and Language experience with leading medical device companies in EMEA, Latin America and APAC. Olga has master’s degree of Healthcare Economics from Universitat Pompeu Fabra and MBA from IE Business School.
Hua Gu
Director
A global product strategy and planning manager, with a Ph.D in Materials Engineering. She has a proven track record in complex product development and launches, strategy formulation and implementation. Hua has an MBA from the University of Chicago Booth School of Business.
Kitty Li
Director
Senior Global Human Resources executive with over 25 years of management experience in Consumer Products, Retail and Manufacturing industries across four continents (Asia, US, Europe, Latin America). Kitty has a proven track record of building successful business startup or turnaround teams via strategic talent management, organization design and culture transformation. Kitty has an MBA from University of Chicago Booth School of Business.
Michael Tung
Director
Mr. Michael Tung is a veteran private equity professional specializing in growth capital, buyout, mergers, restructuring and other types of alternative investment transactions with a wealth of investment experience in the Greater China and global media and retail sectors. Mr. Tung graduated from Syracuse University majoring in Finance.

Advisory Board

Harvey Wu
Global Sourcing, China
Dedicated in Global Sourcing and Supply Chain Practice for Medical Device industry more than 15 years; acquainted with Orthopedic, Wound Care, Sport Medicine and IVD segment, and Mastered design transfer process, product registration process, new product development process. Harvey has an MBA from the University of Chicago Booth School of Business.
Mounang Desai
Healthcare Insights, USA
MD, FACEP. As an executive level healthcare & operations management professional with significant experience that spans over 2 decades, Mounang was a part of a forward-thinking group of physicians that developed and owned one of the most successful acute-care hospitals in the US. Mounang is presently the President of Cypress Emergency Associates (CEA). He has an MBA from the University of Chicago Booth School of Business.
Jason Gu
Startup, USA
An entrepreneur with extensive experience in working VC and companies selling, has a PhD in Materials Science and a Stanford Certified Project Manager. Jason has an MBA from the University of Chicago Booth School of Business.
Alexander Wallstein
Global Operations
Chief Executive Officer at Quasar. Alex Wallstein comes with many years of senior management experience in the medical device industry, including positions at Johnson & Johnson and Medtronic in Minneapolis and Shanghai. Alex received a BS in Medical Computer Science from Ruprecht-Karls-University in Heidelberg, a Master of Engineering from Eidgenössische Technische Hochschule (ETH) Zürich, and an MBA from the University of Chicago.
Ellen Zhang
Strategy, Asia
Ellen has over 15 years’ experience in strategy creation, corporate transformation, innovation, and digital strategy across financial industry, healthcare, TMT, and consumer goods. She graduated from the Peking University and had an MBA with the University of Chicago.

Strategic Investment

We are committed to creating and nurturing a collaborative platform for global innovative MedTechs. By working with leading venture capitalists and private equity funds in healthcare in both China and the larger Asian market, we provide financing assistance to our MedTech projects, accelerating the growth of these businesses by leveraging our advantages in capital.

Matrix Partner China
About us
New Horizon Partner
logo-4
MaxNova Partner in China
MaxNova Partner

News and Media

Partnering with Neorad
08/21/2021

MaxNova reached a strategic partnership agreement with Ne...

MaxNova reached a strategic partnership agreement with Neorad for global markets.
Neorad is a Laser Needle Guidance for Interventional Radiology. Its product SimpliCT uses a laser light to guide any straight needle. Based on a CT image, the laser is set to highlight the intended needle path to the target inside the patient. SimpliCT simply advances the needle by keeping the light on the needle hub, ensures correct needle path, reduces the number of needle passes, and in trials the number of needle passes is consistently reduced to only one in most patients. The smart device increases accuracy, allows the physician to perform more aggressive procedures.

SimpliCT has been proven to be an extremely useful, easy-to-use tool in clinical practice. It saves time and decreases radiation with SimpliCT. Less control scans and needle corrections are necessary, which reduces the treatment time. Less corrections and control images also mean less stress and risk for the patient.

Read More
MaxNova (Shenzhen) Founded
07/16/2021

MaxNova Medical successfully has its Shenzhen subsidiary,...

MaxNova Medical successfully has its Shenzhen subsidiary, MaxNova Medical (Shenzhen) Limited, founded up on July 16, 2021. With the headquarter in Hong Kong, MaxNova now bases its operational centre in Shenzhen, China, where the city was globally recognized as one of the world’s technological centres. CEO Louis Wang puts a significant weight on the Shenzhen subsidiary, expecting to take full advantages of the China resources and market opportunities by leveraging the Shenzhen-based operational centre.

Read More
Partnering with Ruizhi Intelligence
07/07/2021

MaxNova decided to join Ruizhi Intelligence as a sharehol...

MaxNova decided to join Ruizhi Intelligence as a shareholder on Jul 7, 2021.
Ruizhi is a data-driven AI company. Its first product is going to be a diagnosis system that is based on third-generation AI technology. Ruizhi is committed to the service for depression patients, helping the patients with the disease preventing, screening, and management.

Read More
Partnering with BitCare Inc
04/30/2021

MaxNova Medical partnered with BitCare Inc. and became it...

MaxNova Medical partnered with BitCare Inc. and became its shareholder on Apr 30, 2021.
BitCare was newly founded for its first innovative product iScope, which is blockchain-based and designed for gynaecological examination that the users can conveniently operate the process by themselves at home. In the post-Covid era, MaxNova Medical includes the cutting-edge telemedicine project into its emerging medical technology portfolio, so that we help stretch parts of the hospital functions to home-care patients.

Read More
MaxNova Medical Founded
05/27/2020

MaxNova Medical was successfully incorporated in Hong Kon...

MaxNova Medical was successfully incorporated in Hong Kong on May 27, 2020.
The company was founded by a group of healthcare industry practitioners. Louis Wang, the CEO of MaxNova Medical, is confident that as a mission-driven company, MaxNova will be dedicated to discovering, developing, and providing most innovative medical technology products for patients worldwide.

Read More